NORTHWEST BIOTHERAPEUTICS IN's ticker is NWBO and the CUSIP is 66737P600. A total of 12 filers reported holding NORTHWEST BIOTHERAPEUTICS IN in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sentinus, LLC | 2,190,440 | $1,369,025 | 0.46% |
| Moloney Securities Asset Management, LLC | 284,160 | $177,600 | 0.03% |
| Ancora Advisors LLC | 526,000 | $328,750 | 0.01% |
| Opus Capital Group, LLC | 60,150 | $38 | 0.01% |
| Ethos Financial Group, LLC | 22,200 | $13,875 | 0.00% |
| AlphaMark Advisors, LLC | 14,007 | $9 | 0.00% |
| ADVISORS MANAGEMENT GROUP INC /ADV | 10,270 | $6 | 0.00% |
| GRACE & WHITE INC /NY | 14,705 | $9,191 | 0.00% |
| LEE DANNER & BASS INC | 20,000 | $12 | 0.00% |
| Williams Jones Wealth Management, LLC. | 44,000 | $27,500 | 0.00% |
| MAI Capital Management | 20,000 | $12,500 | 0.00% |
| Bartlett & Co. LLC | 4,292 | $3 | 0.00% |
External links
This page lists NORTHWEST BIOTHERAPEUTICS IN's shareholders in Q1 2023. To view NORTHWEST BIOTHERAPEUTICS IN's shareholder history, click here.